drugset / Trial / NCT02712619

Pharmacokinetic-Pharmacodynamic Relationship of Metformin in Healthy Volunteers

NCT02712619 ↗

Phase 1 Completed 20 enrolled Seoul National University Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Two doses of metformin with 12 hour interval * low dose group (375/250 mg) * high dose group (1000/1000mg)

Timeline

Start
2014-05
Primary completion
2014-09
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 250 mg Oral
Subject Metformin Small molecule 1000 mg Oral

Indications

No indication recorded.